ஹாஃப்மேன் லா ரோச் வரையறுக்கப்பட்டவை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹாஃப்மேன் லா ரோச் வரையறுக்கப்பட்டவை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹாஃப்மேன் லா ரோச் வரையறுக்கப்பட்டவை Today - Breaking & Trending Today

RSV Diagnostics Market Size Estimated to Reach $1.3 Billion by 2026


RSV Diagnostics Market Segment Analysis – By Geography
The RSV Diagnostics Market based on Geography can be further segmented into North America (U.S., Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand and Rest of Asia-Pacific), South America(Brazil, Argentina and others), and RoW (Middle East and Africa). North America held the largest share in 2020 with 37.2% of overall market. The growth in this segment is owing to the factors such as increasing number of strategic partnerships among the pharmaceutical companies and in vitro diagnostic manufacturing companies, rising incidences of RSV infections and an increasing infant population. The growing innovations in new technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing in the region is propelling the growth of the market. Asia ....

United States , United Kingdom , Andhra Pradesh , New Zealand , South Korea , Venkat Reddy , Our Custom Research Services , Company Name , Mesa Biotech Inc , Quidel Corporation , Bio Rad Laboratories Inc , Thermofisher Scientifc Inc , Thermo Fisher Scientific Inc , Abbott Laboratories , Hoffmann La Roche , Growing Adoption , Molecular Diagnostic Devices , Syncytial Virus , Diagnostics Market , Market Segment Analysis , Molecular Diagnostics , Direct Fluorescent Antibody , Rapid Antigen Detection Tests , Diagnostic Imaging , Flow Cytometry , Chromatographic Immunoassay ,

Roche's SARS-CoV-2 Rapid Antigen Test approved under Health Canada's Interim Order


increases Canada s testing capacity at the point of care.
Antigen test reliably and quickly triages people suspected of COVID-19 , with results ready in 15 minutes, allowing informed decisions including rapid isolation
The test has a sensitivity of 86.2%-90.0% and a specificity of 97.9%-99.3%, based on 1,106  samples collected from patients  from two independent study centers

The instrument-free testing kit enables convenient use and a seamless workflow for healthcare professionals at different point of care locations or in resource-limited settings
LAVAL, QC, Feb. 17, 2021 /CNW Telbec/ - Subsequent to its global distribution agreement with SD Biosensor Inc.,
Roche Diagnostics, a division of Hoffmann-La Roche Limited, announces that its SARS-CoV-2 Rapid Antigen Test has received approval under Health Canada s Interim Order. This can help healthcare professionals identify a SARS-CoV-2 infection with results typically ready in 15 minutes. ....

Michele Delia , Public Affairs At Roche Diagnostics , Health Canada Interim Order , Affairs At Roche Diagnostics , European Centre For Disease Prevention , Sd Biosensor Inc , Antigen Test , Hoffmann La Roche Limited , Health Canada , Public Affairs , Micheled Elia , Medical Affairs , Antibody Test , Disease Prevention , Roche Diagnostics Canada , Roche Diagnostics , Medical Pharmaceuticals , Health Care Amp Hospitals , Small Cap , Infection Control , Public Safety , Canadian Federal Government , New Products Amp Services , மைக்கேல் டெலியா , பொது வாழ்க்கைத்தொழில்கள் இல் ரோச் பரிசோதனை , ஆரோக்கியம் கனடா இடைக்கால ஆர்டர் ,